Price of NovoSeven injection angers hemophilia patients

Published: 2009-06-11 07:00:00

Updated: 2009-06-11 07:00:00

The final health insurance price for NovoSeven (recombinant activated clotting factor VII ~ rFVIIa) injection 240 KIU (4.8 mg) will be finally decided by the Ministry for Health, Welfare and Family Affair committee, since Novo Nordisk, the maker of the drug, is calling for a more “profitable'' price, while patients are asking for something that is affordable.

The current insurance price of N...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.